The aim of this study was to analyse the clinical characteristics and prognostic factors of @entity3191 ( @entity3191 ) according to the Revised @entity706 (REAL) classification. From 1994 to 1999, 78 @entity1 were diagnosed with @entity3191 , excluding @entity784 and @entity6444 . The distribution of the histological subgroups were: PTCL unspecified (PTCL-U), 40%; @entity706 , 32%; @entity2108 ( @entity2108 ), 17%; angioimmunoblastic @entity784 (AILD), 6%; @entity784 , 3%; and @entity784 , 3%. @entity1 with @entity706 presented with favourable prognostic factors, whereas those with AILD presented with unfavourable prognostic factors. Most @entity1 were treated with @entity632 -containing combination chemotherapy (with or without radiation therapy). The overall complete remission rate was 61.2% (95% Confidence Interval (CI): 48.5-72.8%) and the 5-year probability of failure-free survival was 33.5%. Median survival of all @entity1 was 45 months (range 0-64+ months) and the 5-year probability of survival was 36.2%. In the multivariate analysis, only the International Prognosis Index (IPI) was an independent prognostic factor for overall survival (P<0.01). Taken together, the proportion of @entity706 in this study was higher than that in the studies of Western countries. PTCL responds poorly to treatment with low survival rates and the IPI is a useful prognostic factor for PTCL.

Clinical features of XXXX in 78 @entity1 diagnosed according to the Revised @entity706 (REAL) classification.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity632 :: ('MESH:D004317', 'Chemical') :: ['doxorubicin'] @entity706 :: ('MESH:D008223', 'Disease') :: ['angiocentric lymphoma', 'European-American Lymphoma'] @entity3191 :: ('MESH:D016411', 'Disease') :: ['peripheral T-cell lymphomas', 'PTCLs'] @entity784 :: ('MESH:D016399', 'Disease') :: ['panniculitic T-cell lymphoma', 'T-cell lymphoma', 'cutaneous T-cell lymphomas', 'intestinal T-cell lymphoma'] @entity6444 :: ('MESH:D015461', 'Disease') :: ['T-cell chronic lymphocytic leukaemia'] @entity2108 :: ('MESH:D017728', 'Disease') :: ['anaplastic large cell lymphoma', 'ALCL']
@entity3191 :: (MESH:D016411,Disease) :: ['peripheral T-cell lymphomas']
